Softwr

Healthcare · head to head

Halaxy vs Woebot Health

Halaxy logo

Halaxy

Healthcare

Practice management for allied health that charges nothing for the software and earns on payments

From
Free
Rated
-
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-

The short version

  • Only Halaxy has a free tier, so it costs nothing to try first.
  • Each has a real cost: Halaxy the software being free does not mean the platform is cheap: a clinic taking most payments by card pays roughly 1.5 to 1.9 per cent plus a fixed fee on every transaction, which on a high volume practice comfortably exceeds what a flat AUD 60 per practitioner subscription would have cost.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Halaxy covers No licence fee, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Halaxy and Woebot Health actually diverge.

Attributes where Halaxy and Woebot Health differ
AttributeHalaxyWoebot Health
Starting priceFreeOn request
Pricing modelFree software, revenue taken on payments and creditsquote
Free tierYesNo
PlatformsWeb, iOS, AndroidiOS, Android, Web

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Halaxy

  • No licence fee
  • Integrated claiming
  • Credit-based extras
  • Online booking
  • Clinical notes and templates
  • Card payments
  • Multi-practitioner diary
  • Patient portal

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Halaxy

  • A solo psychologist starting out who wants Medicare and private health claiming without committing to a monthly subscription before there is any incomenot Woebot Health
  • A physiotherapy clinic that wants patient reminders, online booking and card payments reconciled against invoices in one systemnot Woebot Health
  • An NDIS provider that needs claim generation and service agreement tracking built into the same record as clinical notesnot Woebot Health
  • A multi-location allied health group in Australia that wants one diary across sites without paying per practitioner licencesnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Halaxy
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Halaxy
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Halaxy
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Halaxy

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Halaxy

  • The software being free does not mean the platform is cheap: a clinic taking most payments by card pays roughly 1.5 to 1.9 per cent plus a fixed fee on every transaction, which on a high volume practice comfortably exceeds what a flat AUD 60 per practitioner subscription would have cost.
  • Credits are prepaid and consumed by ordinary daily activity including SMS reminders and Medicare claims, so running out mid-week silently stops reminders going to patients, which shows up as no-shows rather than as an error message.
  • Features that competitors treat as standard, including two-way calendar sync, API access and a dedicated SMS number, are locked behind the credit subscription, so the headline free tier is thinner than it first appears.
  • Claiming, funding and payment integrations are deeply Australian, so practitioners in the UK, Canada or the United States get the diary and notes but very little of the automation that makes the product worth choosing.
  • Because the vendor earns on payment volume, its interests and yours diverge on card processing: switching to a cheaper acquirer breaks the automatic reconciliation that is the main operational reason to stay on the platform.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Halaxy

Free
  • HalaxyFree
    • Unlimited practitioners with no subscription fee
    • Diary, patient records, clinical notes and invoicing
    • Online booking page
  • Premium subscription$25/month
    • Priced at 25 credits per month, so roughly AUD 4 to 6 depending on credit rate
    • Two-way calendar sync
    • White-label branding

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Halaxy if

  • You need no licence fee.
  • You want to start without paying.
  • You work on Web, iOS, Android.
  • You also want integrated claiming.

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.

Questions people ask

Is Halaxy or Woebot Health better?
Neither clearly leads. Halaxy starts at Free and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Halaxy or Woebot Health?
Halaxy has a free tier; the other does not. Paid plans start at Free for Halaxy and On request for Woebot Health.
Does Halaxy or Woebot Health run on more platforms?
Halaxy runs on Web, iOS, Android. Woebot Health runs on iOS, Android, Web.
Can I use Halaxy for free?
Yes. Halaxy has a free tier, so you can try it without paying. Woebot Health starts at On request.
What is Halaxy best used for?
Halaxy is most often used for a solo psychologist starting out who wants medicare and private health claiming without committing to a monthly subscription before there is any income, a physiotherapy clinic that wants patient reminders, online booking and card payments reconciled against invoices in one system, an ndis provider that needs claim generation and service agreement tracking built into the same record as clinical notes, a multi-location allied health group in australia that wants one diary across sites without paying per practitioner licences. Of those, a solo psychologist starting out who wants medicare and private health claiming without committing to a monthly subscription before there is any income and a physiotherapy clinic that wants patient reminders, online booking and card payments reconciled against invoices in one system are not what Woebot Health is typically brought in for.
What can Halaxy do that Woebot Health cannot?
Halaxy covers No licence fee, Integrated claiming, Credit-based extras, Online booking. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Halaxy: Is Halaxy genuinely free or is there a hidden subscription?

The core practice management software has no subscription fee for any number of practitioners. Halaxy earns from card processing fees, prepaid credits for SMS and claiming, and an optional premium subscription priced at 25 credits a month.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Halaxy: What does it actually cost a busy clinic?

Budget for card fees of roughly 1.5 to 1.9 per cent plus 75 cents to a dollar per transaction, plus credits at about AUD 0.15 to 0.22 each for every SMS, claim and telehealth session. A clinic with heavy card volume can pay more in total than a flat-rate competitor.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Halaxy: Can I use it outside Australia?

Yes for the diary, notes, invoicing and booking. No for Medicare, DVA, NDIS and Australian health fund claiming, which is where most of the value sits.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Halaxy: Does it handle NDIS?

Yes, including NDIS claim generation, service agreements and plan management alongside clinical records.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

Other head to heads